Cited by 247Stress Responses and CortisolNeuropeptides and Animal PhysiologyMemory and Neural Mechanisms

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress**This research was supported by NIMH Grant MH-50479 and the Undergraduate Research Opportunities Program at the University of Colorado at Boulder.

Deak, Terrence, Nguyen, Kien T., Ehrlich, Andrea L., Watkins, Linda R., Spencer, Robert L., Maier, Steven F., Licinio, Julio, Wong, Ma-Li, Chrousos, George P., Webster, Elizabeth, Gold, Philip W.·1999·Endocrinology

DOI 10.1210/endo.140.1.6415

Open this paper in CoChat — free account

Abstract

The nonpeptide CRH antagonist antalarmin has been shown to block both behavioral and endocrine responses to CRH. However, it's potential activity in blunting behavioral and endocrine sequelae of stressor exposure has not been assessed. Because antagonism of central CRH by alpha-helical CRH attenuates conditioned fear responses, we sought to test antalarmin in this regard. In addition, it remains unclear as to whether this is a result of receptor blockade during conditioning or during testing. Thus, we explored whether CRH mediates the induction or expression of conditioned fear (freezing in a context previously associated with 2 footshocks; 1.0 mA, 5 sec each). Furthermore, because rats previously exposed to inescapable shock (IS; 100 shocks, 1.6 mA, 5 sec each), demonstrate enhanced fear conditioning, we investigated whether this effect would be blocked by antalarmin. Antalarmin (20 mg/kg x 2 ml i.p.) impaired both the induction and expression of conditioned fear. In addition, antalarmin blocked the enhancement of fear conditioning produced by prior exposure to IS. Despite the marked behavioral effects observed in antalarmin-treated rats, antalarmin had no effect on IS-induced rises in ACTH or corticosterone. However, antalarmin did block the ACTH response produced by exposure to 2 footshocks.

Integrity signals

Registry

Crossref · 10.1210/endo.140.1.6415

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Characterization of a 41-Residue Ovine Hypothalamic Peptide that Stimulates Secretion of Corticotropin and β-Endorphin
Vale, W., Spiess, J., RIVIER, C. L., & Rivier, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Learned helplessness: Theory and evidence
Maier, S. F., & Seligman, M. E. (1976) · Journal of Experimental Psychology: General · doi:10.1037/0096-3445.105.1.3 · Cited by 2,494
Self-citation
Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,147
Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression
Chalmers, D., Lovenberg, T. W., & Souza, E. D. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06340.1995 · Cited by 925
Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala
Miserendino, M. J. D., Sananes, C. B., Melia, K. R., & Davis, M. (1990) · Nature · doi:10.1038/345716a0 · Cited by 824
Psychopharmacology: The Fourth Generation of Progress
Kramlinger, K. G. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.10.1021-a · Cited by 779
Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus
Valentino, R. J., Foote, S. L., & Aston‐Jones, G. (1983) · Brain Research · doi:10.1016/0006-8993(83)90615-7 · Cited by 603

Show all 59 references

Research works printed but not linked: 7

De Souza, 1995, Corticotropin-releasing factor: physiology, pharmacology and role in central nervous system and immune disorders., 505
Sawchenko, 1990, Organization of CRF immunoreactive cells and fibers in the rat brain: immunohistochemical studies., 29
Koob, 1990, Behavioral responses to stress-focus on corticotropin-releasing factor., 255
Krahn, 1989, CRH: possible role in eating disorders., Psychiatry Med, 7, 235
Chen, 1994, International Patient
Davis, 1992, A neural systems approach to the study of the amygdala, fear, and anxiety., 45
Weiss, 1985, Neurochemical mechanisms underlying stress-induced depression, 93

Sorted by citations

Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Self-citation
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914
Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor.
Maier, S. F., & Watkins, L. R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.021 · Cited by 737
Self-citation
Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression
Reul, J. M. H. M. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00117-5 · Cited by 515
Neuroendocrine aspects of the response to stress
Miller, D. B., & O'Callaghan, J. P. (2002) · Metabolism · doi:10.1053/meta.2002.33184 · Cited by 496
Stress Hormone Regulation: Biological Role and Translation into Therapy
Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473
Untitled work
(2005) · PubMed · Cited by 470
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
Habib, K. E., Weld, K. P., Rice, K. C., Pushkas, J., Champoux, M., Listwak, S. J., WEBSTER, E. L., Atkinson, A. J., Schulkin, J. A., Contoreggi, C. S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.6079 · Cited by 396
Self-citation
Corticotropin Releasing Factor (CRF) Receptor Signaling in the Central Nervous System: New Molecular Targets
Hauger, R., Risbrough, V. B., Brauns, O., & Dautzenberg, F. M. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950684 · Cited by 344
Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses
Walker, D. L., Miles, L. A., & Davis, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.022 · Cited by 331
Corticotropin-releasing hormone receptor subtypes and emotion
Steckler, T., & Holsboer, F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00170-5 · Cited by 323
Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists
Grammatopoulos, D. K., & Chrousos, G. P. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00670-7 · Cited by 279
Self-citation
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats
Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276
Stress, Endocrine Physiology and Pathophysiology -- Endotext
DeGroot, L. J., Chrousos, G. P., Dungan, K., Grossman, A. B., Jm, H., Koch, C., Korbonits, M., McLachlan, R., New, M., Purnell, J. Q., et al. (2000) · Europe PMC (PubMed Central) · Cited by 260
Self-citation
Role of kappa-opioid receptors in stress and anxiety-related behavior
Veer, A. V., & Carlezon, W. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3195-5 · Cited by 262
Corticotropin-Releasing Hormone and Brain Mast Cells Regulate Blood-Brain-Barrier Permeability Induced by Acute Stress
Esposito, P., Chandler, N., Kandere, K., Basu, S., Jacobson, S., Connolly, R., Tutor, D., & Theoharides, T. C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038497 · Cited by 252
Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety
Gray, J. M., Vecchiarelli, H. A., Morena, M., Lee, T. T. Y., Hermanson, D. J., Kim, A. B., McLaughlin, R. J., Hassan, K. I., Kühne, C., Wotjak, C. T., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2737-14.2015 · Cited by 246
Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH
Weninger, S. C., Dunn, A. J., Muglia, L. J., Dikkes, P., Miczek, K. A., Swiergiel, A. H., Berridge, C. W., & Majzoub, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8283 · Cited by 240
Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice
Ducottet, C., Griebel, G., & Belzung, C. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00051-4 · Cited by 248
Stress, alcohol and drug interaction: an update of human research
Uhart, M., & Wand, G. S. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00131.x · Cited by 240
Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer
Walker, D. L., & Davis, M. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0183-3 · Cited by 231
Role of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression
Hauger, R. L., Risbrough, V., Oakley, R. H., Olivares‐Reyes, J. A., & Dautzenberg, F. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05011.x · Cited by 217
Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes
Sahuque, L. L., Kullberg, E. F., Mcgeehan, A. J., Kinder, J. R., Hicks, M. P., Blanton, M. G., Janak, P. H., & Olive, M. F. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0362-y · Cited by 207
Behavioral effects of neuropeptides in rodent models of depression and anxiety
Rotzinger, S., Lovejoy, D. A., & Tan, L. A. (2010) · Peptides · doi:10.1016/j.peptides.2009.12.015 · Cited by 211
Priming of Long-Term Potentiation in Mouse Hippocampus by Corticotropin-Releasing Factor and Acute Stress: Implications for Hippocampus-Dependent Learning
Blank, T., Nijholt, I. M., Eckart, K., & Spiess, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03788.2002 · Cited by 235
Glucocorticoids, chronic stress, and obesity
Dallman, M. F., Pecoraro, N. C., La Fleur, S. E., Warne, J. P., Ginsberg, A. B., Akana, S. F., Laugero, K. C., Houshyar, H., Strack, A. M., Bhatnagar, S., et al. (2006) · Progress in Brain Research · doi:10.1016/s0079-6123(06)53004-3 · Cited by 198
The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats
Marinelli, P. W., Funk, D. R., Juzytsch, W., Harding, S. E., Rice, K. C., Shaham, Y., & Lê, A. D. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0905-x · Cited by 191
Role of CRF 1 and CRF 2 receptors in fear and anxiety
Takahashi, L. K. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00046-x · Cited by 186
Corticotropin Releasing Hormone Type 2 Receptors in the Dorsal Raphe Nucleus Mediate the Behavioral Consequences of Uncontrollable Stress
Hammack, S. E., Schmid, M. J., LoPresti, M. L., Der‐Avakian, A., Pelleymounter, M. A., Foster, A. C., Watkins, L. R., & Maier, S. F. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-03-01019.2003 · Cited by 176
Self-citation
The therapeutic potential of CRF1 antagonists for anxiety
Zorrilla, E., & Koob, G. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.799 · Cited by 173
The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1β responses to stress
Blandino, P., Barnum, C. J., & Terrence Deak, B. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.021 · Cited by 175
Corticotropin-Releasing Hormone Augments Proinflammatory Cytokine Production from Macrophages In Vitro and in Lipopolysaccharide-Induced Endotoxin Shock in Mice
Agelaki, S., Tsatsanis, C., Gravanis, A., & Margioris, A. N. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6068-6074.2002 · Cited by 171
Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans
Licinio, J., O'Kirwan, F., Irizarry, K. J. L., Merriman, B., Thakur, S., Jepson, R., Lake, S. L., Tantisira, K. G., Weiss, S. T., & Wong, M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001587 · Cited by 173
Self-citation
The Role of Corticotropin-Releasing Hormone in the Dorsal Raphe Nucleus in Mediating the Behavioral Consequences of Uncontrollable Stress
Hammack, S. E., Richey, K. J., Schmid, M. J., LoPresti, M. L., Watkins, L. R., & Maier, S. F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01020.2002 · Cited by 167
Self-citation
Corticotropin Releasing Factor (CRF) Receptor Modulators: Progress and Opportunities for New Therapeutic Agents
Gilligan, P. J., Robertson, D. W., & Zaczek, R. C. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990590f · Cited by 160
Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat
Zorrilla, E. P., Valdez, G. R., Nozulak, J., Koob, G. F., & Markou, A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03189-x · Cited by 159
Stress, Arousal, and Sleep
Sanford, L. D., Suchecki, D., & Meerlo, P. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_314 · Cited by 159
Long-term neuroendocrine and behavioural effects of a single exposure to stress in adult animals
Armario, A., Escorihuela, R. M., & Nadal, R. A. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.04.003 · Cited by 160
The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats
Keck, M. E., Welt, T., Wigger, A., Renner, U., Engelmann, M., Holsboer, F., & Landgraf, R. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01383.x · Cited by 154
Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Merke, D. P., Bornstein, S. R., Avila, N. A., & Chrousos, G. P. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-4-200202190-00012 · Cited by 147
Self-citation
The role of CRH in behavioral responses to stress
Smagin, G. N., Heinrichs, S. C., & Dunn, A. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00384-9 · Cited by 148
Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism
Valdez, G. R., & Koob, G. F. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.020 · Cited by 147
Pharmacological Evidence Supporting a Role for Central Corticotropin-Releasing Factor2 Receptors in Behavioral, but not Endocrine, Response to Environmental Stress
Pelleymounter, M. A., Joppa, M. A., LING, N. C., & Foster, A. C. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.145 · Cited by 147
Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide
Valdez, G. R., Inoue, K., Koob, G. F., Rivier, J., Vale, W., & Zorrilla, E. P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02707-5 · Cited by 143
Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms
Terrence Deak, B., Bordner, K. A., McElderry, N. K., Barnum, C. J., Blandino, P., Deak, M. M., & Tammariello, S. P. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.11.003 · Cited by 143
Overlapping neurobiology of learned helplessness and conditioned defeat: Implications for PTSD and mood disorders
Hammack, S. E., Cooper, M. A., & Lezak, K. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.024 · Cited by 142
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats
Stinus, L., Cador, M., Zorrilla, E. P., & Koob, G. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300487 · Cited by 139
Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei – potential implication for arousal and attention
Sauvage, M. M., & Steckler, T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00137-3 · Cited by 137
Increased Anxiety‐Like Behavior and Ethanol Self‐Administration in Dependent Rats: Reversal via Corticotropin‐Releasing Factor‐2 Receptor Activation
Valdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131
Preterm Birth: Associated Neuroendocrine, Medical, and Behavioral Risk Factors1
Erickson, K., Thorsen, P., Chrousos, G. P., Grigoriadis, D. E., Khongsaly, O., McGregor, J., & Schulkin, J. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7607 · Cited by 131
Self-citation
Considering Sex as a Biological Variable in Basic and Clinical Studies: An Endocrine Society Scientific Statement
Bhargava, A., Arnold, A. P., Bangasser, D. A., Denton, K. M., Gupta, A., Hilliard Krause, L. M., Mayer, E. A., McCarthy, M., Miller, W. L., Raznahan, A., et al. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa034 · Cited by 130
Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy
Bonne, O. B., Grillon, C., Vythilingam, M., Neumeister, A., & Charney, D. S. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.12.001 · Cited by 128
Molecular biology of the CRH receptors— in the mood
Dautzenberg, F. M., Kilpatrick, G. J., Hauger, R. L., & Moreau, J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00388-6 · Cited by 123
Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450
Chaki, S., Nakazato, A., Kennis, L. E. J., Nakamura, M., Mackie, C. E., Sugiura, M., Vinken, P., ASHTON, D. S., Langlois, X., & Steckler, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.032 · Cited by 123
Sensitivity to stress: Dysregulation of CRF pathways and disease development
Bale, T. L. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.01.009 · Cited by 122
Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications
Gold, P. W., Gabry, K. E., Yasuda, M. R., & Chrousos, G. P. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00022-6 · Cited by 114
Self-citation
Corticotropin‐releasing factor 1 receptor‐mediated mechanisms inhibit colonic hypersensitivity in rats
Meerveld, B. G., Johnson, A. C., Cochrane, S. W., Schulkin, J. A., & Myers, D. A. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00648.x · Cited by 111
The Pharmacology of CP‐154,526, a Non‐Peptide Antagonist of the CRH1 Receptor: A Review
Seymour, P. A., Schmidt, A. W., & Schulz, D. W. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00244.x · Cited by 111
Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: Evidence from animal models
Kehne, J. H., & Cain, C. K. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.011 · Cited by 106
On the role of corticotropin-releasing hormone receptors in anxiety and depression
Reul, J. M. H. M., & Holsboer, F. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.1/jreul · Cited by 103
Chronic Administration of the Selective Corticotropin-Releasing Factor 1 Receptor Antagonist CP-154,526: Behavioral, Endocrine and Neurochemical Effects in the Rat
Arborelius, L., Skelton, K. H., Thrivikraman, K. V., Plotsky, P. M., Schulz, D. W., & Owens, M. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39110-4 · Cited by 101
Sex differences in the hypothalamic–pituitary–adrenal axis: An obstacle to antidepressant drug development?
Kokras, N., Hodes, G. E., Bangasser, D. A., & Dalla, C. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14710 · Cited by 98
Exposure to forced swim stress does not alter central production of IL-1
Deak, T., Bellamy, C., & D’Agostino, L. G. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02485-5 · Cited by 94
Anxiolytic Properties of the Selective, Non-peptidergic CRF1 Antagonists, CP154,526 and DMP695 A Comparison to Other Classes of Anxiolytic Agent
Millan, M. J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00244-5 · Cited by 94
Roles for androgens in mediating the sex differences of neuroendocrine and behavioral stress responses
Zuloaga, D. G., Heck, A., Guzman, R. M. D., & Handa, R. J. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00319-2 · Cited by 99
Sex Differences in Stress Response: Classical Mechanisms and Beyond
Hodes, G. E., Bangasser, D. A., Sotiropoulos, I., Kokras, N., & Dalla, C. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231005090134 · Cited by 103
Selective Blockade of Neurokinin-2 Receptors Produces Antidepressant-Like Effects Associated with Reduced Corticotropin-Releasing Factor Function
Steinberg, R., Alonso, R., Griebel, G., Bert, L., Jung, M., Oury-Donat, F., Poncelet, M., Gueudet, C., Desvignes, C., Fur, G. L., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29250-8 · Cited by 93
Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear
Hubbard, D. T., Nakashima, B. R., Lee, I., & Takahashi, L. K. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.001 · Cited by 89
Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.
WEBSTER, E. L., Barrientos, R. M., Contoreggi, C. S., Isaac, M. G., Ligier, S., Gabry, K. E., Chrousos, G. P., McCarthy, E. F., Rice, K. C., Gold, P. W., et al. (2002) · PubMed · Cited by 84
Self-citation
Corticotropin-releasing hormone receptors in the medial prefrontal cortex regulate hypothalamic–pituitary–adrenal activity and anxiety-related behavior regardless of prior stress experience
Jaferi, A., & Bhatnagar, S. (2007) · Brain Research · doi:10.1016/j.brainres.2007.07.100 · Cited by 86
Role of corticotropin-releasing factor, vasopressin and the autonomic nervous system in learning and memory
Croiset, G., Nijsen, M., & Kamphuis, P. J. G. H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00556-2 · Cited by 84
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats
Jutkiewicz, E. M., Wood, S. K., Houshyar, H., Hsin, L., Rice, K. C., & Woods, J. H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2164-z · Cited by 92
Does amygdaloid corticotropin‐releasing hormone (CRH) mediate anxiety‐like behaviors? Dissociation of anxiogenic effects and CRH release
Merali, Z., Khan, S. A., Michaud, D. S., Shippy, S. A., & Anisman, H. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03468.x · Cited by 82
Sex Differences in Corticotropin-Releasing Factor Receptor-1 Action Within the Dorsal Raphe Nucleus in Stress Responsivity
Howerton, A. R., Roland, A. V., Fluharty, J. M., Marshall, A., Chen, A., Daniels, D., Beck, S. G., & Bale, T. L. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.013 · Cited by 80
Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking
Cippitelli, A., Damadzic, R., Hansson, A. C., Singley, E., Sommer, W. H., Eskay, R. L., Thorsell, A., & Heilig, M. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1741-y · Cited by 76
Contextual conditioning in rats as an animal model for generalized anxiety disorder
Luyten, L., Vansteenwegen, D., van Kuyck, K., Gabriëls, L. A., & Nuttin, B. (2011) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-011-0021-6 · Cited by 80
Sickness-related odor communication signals as determinants of social behavior in rat: A role for inflammatory processes
Arakawa, H., Arakawa, K., & Terrence Deak, B. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.01.002 · Cited by 74
The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats
Lodge, D. J., & Lawrence, A. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00793-5 · Cited by 73
Long-term changes in mineralocorticoid and glucocorticoid receptor occupancy following exposure to an acute stressor
Terrence Deak, B., Nguyen, K. T., Cotter, C. S., Fleshner, M., Watkins, L. R., Maier, S. F., & Spencer, R. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02050-8 · Cited by 72
Self-citation
Differential Effects of the CRF-R1 Antagonist GSK876008 on Fear-Potentiated, Light- and CRF-Enhanced Startle Suggest Preferential Involvement in Sustained vs Phasic Threat Responses
Walker, D., Yang, Y., Ratti, E., Corsi, M., Trist, D., & Davis, M. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.210 · Cited by 69
2-Aryloxy-4-alkylaminopyridines: Discovery of Novel Corticotropin-Releasing Factor 1 Antagonists
Chen, Y. L., Obach, R. S., Braselton, J. P., Corman, M. L., Forman, J. T., Freeman, J., Gallaschun, R. J., Mansbach, R. S., Schmidt, A. W., Sprouse, J. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070579c · Cited by 70
Corticotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission: an in vivo microdialysis study in mutant mice
Peñalva, R. G., Flachskamm, C., Zimmermann, S., Wurst, W., Holsboer, F., Reul, J. M. H. M., & Linthorst, A. C. E. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00475-4 · Cited by 70
Corticosterone implants to the amygdala and type 1 CRH receptor regulation: Effects on behavior and colonic sensitivity
Myers, D. A., Gibson, M. S., Schulkin, J. A., & van-Meerveld, B. G. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.001 · Cited by 69
The Role of Corticotropin-Releasing Hormone in the Pathophysiology of Depression: Therapeutic Implications
Lloyd, R. B., & Nemeroff, C. B. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611109060609 · Cited by 67
A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor
Tresadern, G., Bemporad, D., & Howe, T. J. (2009) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2009.01.003 · Cited by 67
Animal Models of Nicotine Exposure: Relevance to Second-Hand Smoking, Electronic Cigarette Use, and Compulsive Smoking
Cohen, A., & George, O. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00041 · Cited by 70
Altered Serotonergic Neurotransmission but Normal Hypothalamic–Pituitary–Adrenocortical Axis Activity in Mice Chronically Treated with the Corticotropin-Releasing Hormone Receptor Type 1 Antagonist NBI 30775
Oshima, A., Flachskamm, C., Reul, J. M. H. M., Holsboer, F., & Linthorst, A. C. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300267 · Cited by 67
Emerging role of alternative splicing of CRF1 receptor in CRF signaling.
Zmijewski, M. A., & Slominski, A. T. (2010) · Acta Biochimica Polonica · doi:10.18388/abp.2010_2366 · Cited by 66
Increased anxiety-like behavior during the post-stress period in mice exposed to repeated restraint stress
Chotiwat, C., & Harris, R. B. S. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.007 · Cited by 64
Differential effects of two corticotropin-releasing factor antagonists on conditioned defeat in male Syrian hamsters (Mesocricetus auratus)
Jasnow, A. M., Banks, M. C., Owens, E. C., & Huhman, K. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02007-7 · Cited by 64
Disruption of the CRF/CRF1 Receptor Stress System Exacerbates the Somatic Signs of Opiate Withdrawal
Papaleo, F., Kitchener, P., & Contarino, A. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.022 · Cited by 63
Long-term effects of early adolescent stress: dysregulation of hypothalamic–pituitary–adrenal axis and central corticotropin releasing factor receptor 1 expression in adult male rats
Li, C., Liu, Y., Yin, S., Cui-yan, L., Liu, D., Jiang, H., & Pan, F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.007 · Cited by 62
Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system
Hashimoto, K., Nishiyama, M., Tanaka, Y., Noguchi, T., Asaba, K., Pournajafi‐Nazarloo, H., Nishioka, T., & Makino, S. (2004) · Peptides · doi:10.1016/j.peptides.2004.05.024 · Cited by 60
Reduced Hypothalamic Vasopressin Secretion Underlies Attenuated Adrenocorticotropin Stress Responses in Pregnant Rats
Ma, S., Shipston, M. J., Morilak, D. A., & Russell, J. A. (2005) · Endocrinology · doi:10.1210/en.2004-1368 · Cited by 60
The Pharmacology of DMP696 and DMP904, Non-Peptidergic CRF1 Receptor Antagonists
Li, Y.-W., Fitzgerald, L. W., Wong, H., Lelas, S., Zhang, G., Lindner, M. D., Wallace, T. L., McElroy, J., Lodge, N. J., Gilligan, P. J., et al. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00034.x · Cited by 59
The role of CRF receptor subtypes in stress-induced behavioural responses
Smagin, G. N., & Dunn, A. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00553-7 · Cited by 58
The influence of stress on the transition from drug use to addiction.
Wand, G. S. (2008) · Europe PMC (PubMed Central) · Cited by 55
Importance of stress receptor‐mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious rat
Johnson, A. C., Tran, L., Schulkin, J. A., & Meerveld, B. G. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01899.x · Cited by 56

Authors: Deak, T., Nguyen, K. T., Ehrlich, A. L., Watkins, L. R., Spencer, R. L., Maier, S. F., Licinio, J., Wong, M.-L., Chrousos, G. P., Webster, E., & Gold, P. W.
Affiliations: Department of Psychology (T.D., K.T.N., A.L.E., L.R.W., R.L.S., S.F.M.), University of Colorado, Boulder, Colorado 80309-0345;
University of Colorado Boulder (US)
Clinical Neuroendocrinology Branch (J.L., M.-L.W., P.W.G.), National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892-1284;
National Institutes of Health (US)
ORCID: Nguyen, Kien T.
Watkins, Linda R.
Spencer, Robert L.
Maier, Steven F.
Wong, Ma-Li
Chrousos, George P.
Gold, Philip W.
Venue: Endocrinology
Publisher: The Endocrine Society
Published: 1999-01-01
Volume: 140
Issue: 1
Pages: 79-86
ISSN: 0013-7227 (ISSN-L)
1945-7170
DOI: 10.1210/endo.140.1.6415
OpenAlex: W2149878393
Cited by: 242
References: 59
Citations by year: 2026: 2 · 2025: 1 · 2024: 5 · 2023: 4 · 2021: 2 · 2020: 5 · 2019: 7 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 4 · 2014: 9 · 2013: 5 · 2012: 8
FWCI: 8.90
Type: journal article
Language: en
Open access: closed
Locations: Endocrinology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Mental Health (MH 50479)
Topics: Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
Keywords: antalarmin, corticotropin-releasing factor, fear conditioning, freezing behavior, inescapable shock, stress, ACTH, corticosterone, stress response
MeSH terms: Adrenal Cortex Hormones, Adrenocorticotropic Hormone, Animals, Behavior, Animal, Conditioning, Operant, Corticotropin-Releasing Hormone, Electroshock, Escape Reaction, Fear, Male, Pituitary-Adrenal System, Pyrimidines, Pyrroles, Stress, Physiological, Rats, Sprague-Dawley, Receptors, Corticotropin-Releasing Hormone, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress**This research was supported by NIMH Grant MH-50479 and the Undergraduate Research Opportunities Program at the University of Colorado at Boulder.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks